- FT NewsFT News
- Press releasesPress releases
- Events & ActivityEvents & Activity
- Pharma recovers composure as price concerns ease
- US biotech shares tumble as Trump warns on soaring drug prices
- Biogen predicts preventive drug for Alzheimer's disease
- Biogen and Ionis Pharmaceuticals climb on upbeat drug trials
- Biosimilars set topple two of the world's biggest drug franchises
Biogen Inc (BIIB:NSQ) closed at 280.57, -8.71% below its 52-week high of 307.33, set on Aug 02, 2016.
205.42Jun 27 2016307.33Aug 02 2016
Markit short selling activity
|Market cap||59.10bn USD|
|EPS (TTM)||15.95 |
Data delayed at least 15 minutes, as of Jun 22 2017 21:00 BST.